Neuralstem Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
16,846.10
27,526.50
12,234.00
20,194.90
11,674.90
5,787.10
Total Accounts Receivable
10.00
225.50
37.30
63.60
371.60
358
Other Current Assets
255.70
274.10
1,159.80
646.20
402.30
363.30
Total Current Assets
17,111.80
28,026.10
13,431.10
20,904.70
12,448.80
6,508.40
Net Property, Plant & Equipment
231.00
301.30
343.20
269.60
172.90
90.30
Long-Term Note Receivable
-
-
-
424.20
365.50
298.20
Intangible Assets
1,137.70
1,233.20
1,103.50
990.20
883.50
763.50
Other Assets
933.10
283.60
71.80
15.70
13.90
24
Total Assets
19,413.50
29,844.10
14,949.50
22,604.30
13,884.50
7,684.50
ST Debt & Current Portion LT Debt
2,763.10
730.00
4,545.20
3,705.80
-
Accounts Payable
1,196.20
-
1,455.80
2,343.90
875.10
Other Current Liabilities
1,976.80
3,278.70
424.50
1,283.70
639.50
Total Current Liabilities
5,936.10
4,008.70
6,425.50
7,333.40
1,514.60
Long-Term Debt
4,934.20
8,056.50
3,382.70
-
-
Other Liabilities
125.00
59.60
174.10
3,940.10
3,854.80
Total Liabilities
10,995.30
12,124.70
9,982.30
11,273.60
5,369.30
Common Equity (Total)
8,418.20
17,719.30
4,967.30
11,320.80
8,505.10
Total Shareholders' Equity
8,418.20
17,719.30
4,967.30
11,330.80
8,515.10
Total Equity
8,418.20
17,719.30
4,967.30
11,330.80
8,515.10
Liabilities & Shareholders' Equity
19,413.50
29,844.10
14,949.50
22,604.30
13,884.50
Preferred Stock (Carrying Value)
-
-
-
10.00
10.00

About Neuralstem

View Profile
Address
20271 Goldenrod Lane
Germantown Maryland 20876
United States
Employees -
Website http://www.neuralstem.com
Updated 07/08/2019
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I.